Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Similar articles for PubMed (Select 24120666)

1.

The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis.

Gupta GP, Vanness K, Barlas A, Manova-Todorova KO, Wen YH, Petrini JH.

Mol Cell. 2013 Nov 7;52(3):353-65. doi: 10.1016/j.molcel.2013.09.001. Epub 2013 Oct 10.

2.

Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.

Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Jun 4;279(23):24745-56. Epub 2004 Mar 25.

3.

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.

Cancer Res. 2003 Jun 15;63(12):3395-402.

4.

Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.

Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K.

Am J Pathol. 2013 Oct;183(4):1339-50. doi: 10.1016/j.ajpath.2013.06.027. Epub 2013 Aug 11.

5.

PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

Cortez V, Samayoa C, Zamora A, Martinez L, Tekmal RR, Vadlamudi RK.

Cancer Res. 2014 Dec 15;74(24):7395-405. doi: 10.1158/0008-5472.CAN-14-0993. Epub 2014 Nov 6.

PMID:
25377474
6.

The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.

D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG.

Cancer Res. 2004 Jun 15;64(12):4122-30.

7.

The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Evangelou K, Bartkova J, Kotsinas A, Pateras IS, Liontos M, Velimezi G, Kosar M, Liloglou T, Trougakos IP, Dyrskjot L, Andersen CL, Papaioannou M, Drosos Y, Papafotiou G, Hodny Z, Sosa-Pineda B, Wu XR, Klinakis A, Ørntoft T, Lukas J, Bartek J, Gorgoulis VG.

Cell Death Differ. 2013 Nov;20(11):1485-97. doi: 10.1038/cdd.2013.76. Epub 2013 Jul 12.

8.

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.

Nat Cell Biol. 2007 May;9(5):493-505. Epub 2007 Apr 22.

PMID:
17450133
9.

Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.

Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV.

Cancer Res. 2001 Dec 15;61(24):8811-9.

10.

Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells.

Zhao C, Meng L, Hu H, Wang X, Shi F, Wang Y, Li Q, Lin A.

BMC Cell Biol. 2010 Oct 22;11:82. doi: 10.1186/1471-2121-11-82.

11.

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M.

Nat Genet. 2000 Nov;26(3):291-9.

PMID:
11062467
12.

Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.

Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, dal Zuffo R, Matti V, d'Ario G, Montani E, Mercurio C, Hahn WC, Gorgoulis V, Minucci S, d'Adda di Fagagna F.

Nat Cell Biol. 2011 Mar;13(3):292-302. doi: 10.1038/ncb2170. Epub 2011 Feb 20.

13.

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ Jr.

Nat Genet. 2004 Apr;36(4):343-50. Epub 2004 Feb 29.

PMID:
14991053
14.

PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.

Schade B, Rao T, Dourdin N, Lesurf R, Hallett M, Cardiff RD, Muller WJ.

J Biol Chem. 2009 Jul 10;284(28):19018-26. doi: 10.1074/jbc.M109.018937. Epub 2009 May 12.

15.
16.

A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):117-9.

PMID:
19408105
17.

Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.

Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, Chodosh LA, Cardiff RD, Gunther EJ.

J Clin Invest. 2008 Jan;118(1):51-63.

18.

Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response.

Swarbrick A, Roy E, Allen T, Bishop JM.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5402-7. doi: 10.1073/pnas.0801505105. Epub 2008 Mar 31.

19.

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.

Reimann M, Loddenkemper C, Rudolph C, Schildhauer I, Teichmann B, Stein H, Schlegelberger B, Dörken B, Schmitt CA.

Blood. 2007 Oct 15;110(8):2996-3004. Epub 2007 Jun 11.

20.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk